Bausch + Lomb (BLCO) vs Warby Parker (WRBY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Bausch + Lomb (BLCO) has outperformed Warby Parker (WRBY) over the past year, gaining 16.6% versus a gain of 1.4%. Bausch + Lomb is the larger company by market cap ($6.13 billion vs $3.08 billion), about 2.0 times the size, while Warby Parker is growing revenue faster (+13.0% vs +6.5%). On valuation, Bausch + Lomb trades at a lower forward P/E (15.4x vs 40.6x for Warby Parker).
Warby Parker converts more of its revenue into profit, with a net margin of 0.2% versus -7.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLCO | WRBY |
|---|---|---|
| Share price | $17.15 | $24.95 |
| Market cap | $6.13B | $3.08B |
| 1-day change | -1.10% | -1.42% |
| YTD return | +0.41% | +14.50% |
| 1-year return | +16.59% | +1.42% |
| 5-year return | — | -54.43% |
| P/E ratio (TTM) | — | 415.83 |
| Forward P/E | 15.40 | 40.58 |
| EPS (TTM) | $-0.49 | $0.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $5.10B | $871.90M |
| Revenue growth (YoY) | +6.47% | +13.04% |
| Net income (latest FY) | $-360.00M | $1.64M |
| Gross margin | — | 53.97% |
| Operating margin | 2.22% | -0.61% |
| Net margin | -7.06% | 0.19% |
| 52-week high | $18.92 | $31.00 |
| 52-week low | $13.77 | $14.96 |
| Distance from 52-week high | -9.33% | -19.52% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +13.06% | +22.08% |
| Average volume | 393.43K | 2.85M |
| Shares outstanding | 357.17M | 108.24M |
| Employees | 13,000 | 2,275 |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BLCO has outperformed WRBY by 15.2 percentage points over the past year.
- Warby Parker is more profitable, keeping 0.2 cents of every revenue dollar as net income versus -7.1 cents for Bausch + Lomb.
- Warby Parker grew revenue faster in its latest fiscal year (+13.04% vs +6.47%).
About Bausch + Lomb
BLCO stock →Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical.
Health Care · Ophthalmic Goods · 13,000 employees
About Warby Parker
WRBY stock →Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada.
Health Care · Ophthalmic Goods · 2,275 employees
BLCO vs WRBY FAQ
Which is bigger, Bausch + Lomb or Warby Parker?
Bausch + Lomb (BLCO) is larger, with a market capitalization of $6.13B compared with $3.08B for Warby Parker (WRBY).
Which stock has performed better over the past year, BLCO or WRBY?
BLCO returned +16.59% over the past 12 months, compared with +1.42% for WRBY (price return, excluding dividends). Past performance does not predict future results.
Are Bausch + Lomb and Warby Parker in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.